TGF β for Immuno-Oncology Drug Development
Expression of a TGF-β Inhibitor from an Oncolytic Vaccinia Virus
From Cell Signaling to the Tumor Microenvironment, Exploit TGF-β’s Role in IO to Harness a Clinically Relevant, Safe & Efficacious Therapeutic.
SPEAKER : Steve Thorne
13TH INTERNATIONAL ONCOLYTIC VIRUS CONFERENCEOncolytic Viruses Symposium
The VET Platform: Re-targeting Oncolytic Vaccinia Virus to Tumors through Expression of Chemokine Receptors
SPEAKER : Steve Thorne
Oncolytic Virotherapy Summit
Boston | MA
The Design of Oncolytic Viral Therapies for Intravenous Delivery
SPEAKER : Steve Thorne
Oncolytic Viruses Symposium
Oxford Global
A Dual Pipeline Strategy Bringing Potent Vaccinia-Based Oncolytic Immunotherapies to the Clinic
SPEAKER : Steve Thorne
